TapewireFind a company

person · Reporting owner

Paunovich Vukasin

Disclosed activity across 2 companies

Tapewire entity
10161
SEC CIK
0001938690

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
American Well CorpAMWL · Entity 2112EVP, Enterprise PlatformsJanuary 02, 2025January 06, 2025
LifeStance Health Group, Inc.LFST · Entity 3936Chief Technology OfficerSeptember 02, 2026September 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

American Well Corp

Report date January 02, 2025 · Filed January 06, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect116,121 Reported balance After 2025-01-02 transaction · row 1
1 source row

Row 1 · 2025-01-02 · Sale · Disposed 444 · Balance 116,121

F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 2, 2025. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 2, 2025. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

LifeStance Health Group, Inc.

Report date September 02, 2026 · Filed September 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect205,379 Reported balance After 2026-09-02 transaction · row 1
1 source row

Row 1 · 2026-09-02 · Sale · Disposed 42,067 · Balance 205,379

F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $12.86 to $12.905 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $12.86 to $12.905 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 02, 2026 Filed Sep 4, 2026 20:51 UTC LifeStance Health Group, Inc. LFST · Entity 3936 SaleCommon Stock 42,067 $12.87 $541,402.29
Disclosure

SEC source: 0001193125-26-383783 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,379

F1 · shares: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $12.86 to $12.905 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 21:07 UTC LifeStance Health Group, Inc. LFST · Entity 3936 SaleCommon Stock 44,394 $10.85 $481,674.90
Disclosure

SEC source: 0001193125-26-347131 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 247,446

Read SEC document
June 11, 2026 Filed Jun 16, 2026 00:41 UTC LifeStance Health Group, Inc. LFST · Entity 3936 Tax withholdingCommon Stock 17,456 $8.61 $150,296.16
Disclosure

SEC source: 0001193125-26-271521 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,840

F1 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on June 11, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 22:59 UTC LifeStance Health Group, Inc. LFST · Entity 3936 Tax withholdingCommon Stock 18,541 $6.91 $128,118.31
Disclosure

SEC source: 0001193125-26-102640 · ownership.xml · nonDerivative · entry 2

Paunovich Vukasin · CIK 0001938690 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 309,296

F2 · kind: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 22:59 UTC LifeStance Health Group, Inc. LFST · Entity 3936 GrantCommon Stock 62,935 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-102640 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,837

F1 · shares: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on June 11, 2025, which vested on March 9, 2026.

Read SEC document
March 05, 2026 Filed Mar 10, 2026 00:11 UTC LifeStance Health Group, Inc. LFST · Entity 3936 GrantCommon Stock 86,331 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-099062 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,902

F1 · shares: Includes 86,331 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 23:37 UTC LifeStance Health Group, Inc. LFST · Entity 3936 GrantCommon Stock 178,571 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-086461 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,571

F1 · shares: Includes 178,571 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:30 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 444 $7.17 $3,182.95
Disclosure

SEC source: 0000950170-25-002191 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,121

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 2, 2025. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 21:41 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 3,213 $9.22 $29,631.57
Disclosure

SEC source: 0000950170-24-133312 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,565

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on December 2, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 21:04 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 398 $9.15 $3,643.41
Disclosure

SEC source: 0000950170-24-112477 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,778

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on October 1, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 22:48 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 3,141 $7.87 $24,725.64
Disclosure

SEC source: 0000950170-24-104170 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,176

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on September 1, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

F2 · balance_after: On July 10, 2024, the issuer effected a 1-for-20 reverse split of the issuer's common stock, resulting in proportionate adjustments to the number of shares of Class A common stock beneficially owned by the reporting person, including shares underlying outstanding restricted stock units ("RSUs"). Accordingly, the securities reported on this Form 4 have been adjusted to reflect the 1-for-20 reverse stock split.

F3 · balance_after: Securities Beneficially Owned includes shares acquired pursurant to the Issuer's employee stock purchase plan in transaction except under Rule 16b-3.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:54 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 7,956 $0.30 $2,415.44
Disclosure

SEC source: 0000950170-24-080631 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,461,133

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on July 1, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:47 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 62,810 $0.41 $26,041.03
Disclosure

SEC source: 0000950170-24-069382 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,469,089

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on June 1, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

F2 · balance_after: Due to an administrative error, on previous filings, the reporting person inadvertently reported an incorrect total number of securities beneficially owned, which had not included securities held by the reporting person prior to becoming an insider of the issuer. The total number has been corrected on this Form 4.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:36 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 31,712 $1.07 $33,976.24
Disclosure

SEC source: 0000950170-24-026072 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,517,546

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on March 1, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

F2 · balance_after: Securities Beneficially Owned includes shares acquired purusant to the Issuer's employee stock purchase plan in trasnsaction exempt under Rule 16b-3.

Read SEC document
February 23, 2024 Filed Feb 23, 2024 22:01 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 251,323 $1.09 $274,369.32
Disclosure

SEC source: 0000950170-24-019467 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,535,635

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on February 22, 2024. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 22:05 UTC American Well Corp AMWL · Entity 2112 GrantClass A Common Stock 2,171,646 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-018903 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,786,958

F1 · shares: Represents a grant of restricted stock units, with 25% of the RSUs shall vest two (2) days after the date of grant. The remaining RSUs shall vest in equal increments every three (3) months thereafter (beginning on the first calendar day of the month following the date that is three months following the date of grant) for three (3) years, until such RSU is vested in full on the first day of the calendar month following the three (3) year anniversary of the date of grant.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:31 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 58,409 $1.07 $62,445.06
Disclosure

SEC source: 0000950170-24-005422 · ownership.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 615,312

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 15, 2024. The sales were effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

F2 · balance_after: Securities Beneficially Owned includes shares acquired pursuant to the Issuer's employee stock purchase plan in a transaction exempt under Rule 16b-3.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 00:21 UTC American Well Corp AMWL · Entity 2112 SaleClass A Common Stock 104,832 $2.16 $226,007.31
Disclosure

SEC source: 0001209191-23-042667 · doc4.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,761

F1 · kind: The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on July 15, 2023. The sales were effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:29 UTC American Well Corp AMWL · Entity 2112 GrantPerformance Share Units · Derivative 274,378 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015810 · doc4.xml · derivative · entry 2

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,378

Underlying: Class A Common Stock · 274,378 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending February 28, 2026, and may be earned between 0%-150% of target levels, based upon the Issuer's achievement of specified stock price performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified.

F2 · derivative.exercise_date: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending February 28, 2026, and may be earned between 0%-150% of target levels, based upon the Issuer's achievement of specified stock price performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified.

F2 · derivative.expiration_date: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending February 28, 2026, and may be earned between 0%-150% of target levels, based upon the Issuer's achievement of specified stock price performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:29 UTC American Well Corp AMWL · Entity 2112 GrantClass A Common Stock 274,378 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-015810 · doc4.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 769,593

F1 · shares: Represents a grant of restricted stock units, with 25% vesting upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining vesting every 3 months thereafter over a three-year period (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date).

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:31 UTC American Well Corp AMWL · Entity 2112 GrantPerformance Share Units · Derivative 563,266 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-042656 · doc4.xml · derivative · entry 3

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 563,266

Underlying: Class A Common Stock · 563,266 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending July 14, 2025, and may be earned between 0%-300% of target levels, based upon the Issuer's achievement of specified market capitalization performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified.

F2 · derivative.exercise_date: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending July 14, 2025, and may be earned between 0%-300% of target levels, based upon the Issuer's achievement of specified market capitalization performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified.

F2 · derivative.expiration_date: Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending July 14, 2025, and may be earned between 0%-300% of target levels, based upon the Issuer's achievement of specified market capitalization performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified.

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:31 UTC American Well Corp AMWL · Entity 2112 Tax withholdingClass A Common Stock 68,051 $4.25 $289,216.75
Disclosure

SEC source: 0001209191-22-042656 · doc4.xml · nonDerivative · entry 2

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 495,215

Read SEC document
July 15, 2022 Filed Jul 20, 2022 01:31 UTC American Well Corp AMWL · Entity 2112 GrantClass A Common Stock 563,266 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-042656 · doc4.xml · nonDerivative · entry 1

Paunovich Vukasin · CIK 0001938690 · EVP, Enterprise Platforms

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 563,266

F1 · shares: Represents a grant of restricted stock units, with 40% vesting upon the grant date, 40% vesting on the first anniversary of the grant date, and the remaining 20% vesting upon the 18th month anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.